Related Experiment Video

Updated: Dec 19, 2025

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

1.1K

Chimeric Antigen Receptor T Cell Immunotherapy: What You Need to Know #393

Ramy Sedhom, Arjun Gupta, Areej El-Jawahri

    Journal of Palliative Medicine
    |June 5, 2020
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Author Spotlight: Advancements in CAR-T Cell Manufacturing and Gene Therapy Production06:18

    Author Spotlight: Advancements in CAR-T Cell Manufacturing and Gene Therapy Production

    Published on: August 18, 2023

    3.5K
    Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy06:51

    Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

    Published on: December 17, 2019

    15.7K

    Related Concept Videos

    Tumor Immunotherapy01:27

    Tumor Immunotherapy

    Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
    1.6K